News Express: UM SKL-QRCM, Hubei Shizhen Laboratory co-organise seminar

新聞快訊:澳大中藥質量研究國家重點實驗室與湖北時珍實驗室合辦研討會

 

澳大中藥質量研究國家重點實驗室與湖北時珍實驗室合辦研討會
UM SKL-QRCM, Hubei Shizhen Laboratory co-organise seminar

 


澳大中藥質量研究國家重點實驗室與湖北時珍實驗室合辦研討會

為探索中醫藥守正創新的新方向,促進中醫藥事業傳承與創新,搭建中醫藥臨床與基礎科研交流平台,澳門大學中藥質量研究國家重點實驗室與湖北時珍實驗室合辦中醫藥前沿研討會,吸引了一眾中醫藥專家、研究人員和師生參與。

研討會共有五個學術報告。湖北中醫藥大學中醫大師張六通以“中醫衰老學說若干問題的思考”為題,提出了衰老病機證型的臟虛絡痹學說,為更準確地使用中醫藥防治衰老相關疾病提供了理論指導。湖北中醫藥大學校長陳剛以“中醫藥與老年慢病防治”為題,圍繞老年慢病深入淺出地闡述了中醫藥在治未病中的主導作用、在重大疾病中的協同作用,以及在疾病康復過程中的核心作用。湖北中醫藥大學教授向楠分享了時珍學術思想的繼承與發展,深入探討了醫藥雙聖李時珍的學術成就、李時珍學術思想中“痰”的概念及其在現代疾病治療中的應用。澳大中華醫藥研究院院長、中藥質量研究國家重點實驗室主任陳新探討了中藥免疫調節作用的細胞及分子機制,闡述了中藥通過多種途徑調控免疫系統功能,從而預防和治療多種疾病。澳大中藥質量研究國家重點實驗室助理主任王勝鵬則分享了中醫經典名方研發的實踐與思考,闡述了現階段經典名方研發瓶頸和前沿研發思路。

此外,澳大校長宋永華還與湖北時珍實驗室代表團會面,雙方就進一步落實中醫藥研發合作、人才交流、成果轉化、協同創新等具體內容進行了深入交流,一致表示將更好利用鄂澳兩地的科技人才、技術平台及自然資源,持續推動中醫藥學術交流、加快兩地中醫藥產業聯動發展,提升中醫藥國際影響力。

欲瀏覽官網版可登入以下連結:
https://www.um.edu.mo/zh-hant/news-and-press-releases/campus-news/detail/59898/


UM SKL-QRCM, Hubei Shizhen Laboratory co-organise seminar

The State Key Laboratory of Quality Research in Chinese Medicine (SKL-QRCM) of the University of Macau (UM) and Hubei Shizhen Laboratory co-organised the Traditional Chinese Medicine Frontier Seminar. The seminar aimed to explore new directions in the advancement of Chinese medicine, promote the development and innovation of Chinese medicine, and provide an exchange platform for clinical research and basic research in Chinese medicine. It was well attended by Chinese medicine experts, researchers, faculty, and students.

The seminar featured five academic presentations, which were given by Chinese medicine expert Zhang Liutong, President Chen Gang, and Professor Xiang Nan from Hubei University of Chinese Medicine; Chen Xin, director of the Institute of Chinese Medical Sciences and director of SKL-QRCM of UM; and Wang Shengpeng, assistant director of SKL-QRCM of UM. In addition, UM Rector Yonghua Song met with the delegation from Hubei Shizhen Laboratory and held in-depth discussions on cooperation in research and development of Chinese medicine, talent cultivation, transformation of research results, and collaborative innovation. Both parties expressed their commitment to leveraging the science and technology talent, technology platforms, and natural resources of Macao and Hubei to promote academic exchanges in Chinese medicine, accelerate the integrated development of the Chinese medicine industry in the two places, and enhance the international influence of Chinese medicine.

To read the news on UM’s official website, please visit the following link:
https://www.um.edu.mo/news-and-press-releases/campus-news/detail/59898/